Ignite Creation Date:
2025-12-24 @ 2:02 PM
Ignite Modification Date:
2026-02-27 @ 10:38 AM
Study NCT ID:
NCT02194595
Status:
COMPLETED
Last Update Posted:
2022-04-11
First Post:
2014-07-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
Sponsor:
Mount Sinai Hospital, Canada
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09
Start Date Type:
None
Primary Completion Date:
2021-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-16
First Submit QC Date:
None
Study First Post Date:
2014-07-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-07
Last Update Post Date:
2022-04-11
Last Update Post Date Type:
ACTUAL